DESIGN THERAPEUTICS INC reports a Return on Equity (ROE) of -31.97%.

What is DSGN's dividend yield?

DESIGN THERAPEUTICS INC offers a dividend yield of 0.00%.

What is DSGN's Deepscope Quality Score?

Deepscope rates DSGN's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy DSGN?

Deepscope's AI Timing Score for DSGN is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does DSGN belong to?

DESIGN THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

DSGN (NASDAQ) Stock Analysis | DESIGN THERAPEUTICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

DSGN

DESIGN THERAPEUTICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 89

USD 10.44

0.27 (2.65%) Day Change

Watchlist Portfolio Compare Chart

0.00

D/E

-32.0%

ROE

-30.3%

ROA

0.00%

Div Yield

DESIGN THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 10.44 Price 0.27 (2.65%) Day Change	NEWS SCORE: 89

DSGN, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	10.44
PBV / Sector	2.91 / 4.48
Earning Per Share	-1.15

PE / Sector	N/A / 16.68
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	14.86 M GREAT
Average 1W Daily Value	11.31 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 450.37
NPM Average (%) / Sector	N/A / -1,506.30
NPM Change Average (%) / Sector	N/A / 4,941.44
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-30.25 / 30.83
ROA Average (%) / Sector	-24.21 / -347.12
ROA Change Average (%) / Sector	18.61 / 5,126.35 GOOD
ROE (%) / Sector	-31.97 / -3.04
ROE Average (%) / Sector	-25.46 / 40.76
ROE Change Average (%) / Sector	19.30 / 2,110.63 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

Registration Details

Analyze Date	2026-06-04 09:24:23
Symbol	DSGN
Name	DESIGN THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	62.46 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	635.19 / 8,483.11

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 6005 Hidden Valley Road, Carlsbad, CA, United States, 92011

Phone: 858 293 4900

Website: https://www.designtx.com

Employees: 54

Sector: Healthcare >> Biotechnology

Description: Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. The company was incorporated in 2017 and is headquartered in Carlsbad, California.